Regulatory Guidance on Using Re-Test Dates in Global Markets
The pharmaceutical industry often faces a complex regulatory landscape when dealing with re-test periods for APIs and intermediates. While shelf life is fixed for finished drug products, re-test periods allow materials like active substances and intermediates to be retested and reused if they remain within specification. However, the rules around how re-test dates should be…
Read More “Regulatory Guidance on Using Re-Test Dates in Global Markets” »